Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification

Links shared publicly online about this topic.

  • 925
    total visits

Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification

news-medical.net

The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.

View full resource at news-medical.net

Tags: Vaccination, Meningitis, Healthy Living, Children's Health, Vaccine, Pfizer, News

  • Share

Most Recently Shared on August 24, 2010 at 5:19 am By:

Meningitis_News News-Medical.Net

Meningitis News: Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The Wor... http://bit.ly/d3rUrU

2 years ago...

WHO grants prequalification to Prevenar 13, Pfizer's 13-valent pneumococcal conjugate vaccine for infants & young children - Biotechnology

pharmabiz.com — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeksView full resource at pharmabiz.com

  • View Related
  • Share

Most Recently Shared on August 24, 2010 at 11:13 am By:

Lung_Breathing Lungs and Breathing OW Health

WHO grants prequalification to Prevenar 13, Pfizer's 13-valent pneumococcal conjugate vaccine for infants & young ... http://bit.ly/an8GLZ

2 years ago...

Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification

news-medical.net — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 24, 2010 at 5:13 am By:

Lung_Breathing Lungs and Breathing OW Health

Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The World Health Organiz... http://bit.ly/c8uCg5

2 years ago...

Advertisement